Renal Soluble Guanylate Cyclase Is Downregulated in Sunitinib‐Induced Hypertension
Background The tyrosine kinase inhibitor sunitinib causes hypertension associated with reduced nitric oxide (NO) availability, elevated renal vascular resistance, and decreased fractional sodium excretion. We tested whether (1) nitrate supplementation mitigates sunitinib‐induced hypertension and NO...
Main Authors: | Jeannine Witte, Melanie Mühlbauer, Diana Braun, Antje Steinbach, Janine Golchert, Rainer Rettig, Olaf Grisk |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-09-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.118.009557 |
Similar Items
-
Structural Perspectives on the Mechanism of Soluble Guanylate Cyclase Activation
by: Elizabeth C. Wittenborn, et al.
Published: (2021-05-01) -
Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
by: Arpeeta Sharma, et al.
Published: (2023-07-01) -
Allosteric activation of the nitric oxide receptor soluble guanylate cyclase mapped by cryo-electron microscopy
by: Benjamin G Horst, et al.
Published: (2019-09-01) -
Soluble guanylate cyclase stimulators and activators: new horizons in the treatment of priapism associated with sickle cell disease
by: Dalila Andrade Pereira, et al.
Published: (2024-02-01) -
Soluble guanylate cyclase mediates the relaxation of healthy and inflamed bladder smooth muscle by aqueous nitric oxide
by: Patrik Aronsson, et al.
Published: (2023-09-01)